Previous attempted therapies for heart failure have shown improvements to heart function on the order of 5-10%. cBIN1 gene therapy improved function by 30%. "It's night and day," Shaw adds.

A new gene therapy reversed heart failure in pigs by repairing heart function through cBIN1, showing major promise for future ...

New Gene Therapy Reverses Heart Failure in Large Animal Model Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart ...

The treatment, which could take only 30 minutes, increases blood flow through parts of the heart damaged by attacks or clogged by fat. Patients with severe coronary heart disease, whom doctors ...

Bayer’s AskBio gene therapy unit has started recruiting patients into a phase 2 trial of its AB-1002 candidate for congestive heart failure (CHF), buoyed by encouraging data from a first-in ...

Nuevocor Pte. Ltd. has closed a $45 million series B, enabling it to move lead gene therapy NVC-001 into the clinic in the treatment of an inherited form of cardiomyopathy. BioWorld Science Science ...

To help achieve more precise control of gene therapy, engineers have designed a new control circuit that can keep gene expression levels within a target range. The method could be used to deliver ...

Verve has been working on a one-time treatment that can prevent heart attacks for life by making a precise edit to a liver gene called PCSK9 ... testing of that first therapy and pivoted to ...

Nuevocor is developing a one-time gene therapy for heart failure patients. Inovio taking on Covid again, almost 3 years after abandoning vaccine CEO says biotech firm is on path to $1B in revenue ...

Nuevocor Pte. Ltd. has closed a $45 million series B, enabling it to move lead gene therapy NVC-001 into the clinic in the treatment of an inherited form of cardiomyopathy.